Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11442558 | 0.82 | CD44 (0.41) | CD44KDM4EALDH1A1MAPTTP53 | |
| SCHEMBL8466087 | 0.74 | TSHR (0.48) | CD44KDM4EALDH1A1MAPTCYP3A4 | |
| SCHEMBL28684099 | 0.74 | CYP3A4 (0.37) | ALDH1A1MAPTTP53CYP3A4TDP1 | |
| SCHEMBL15089832 | 0.74 | CYP3A4 (0.37) | CD44ALDH1A1MAPTTP53CYP3A4 | |
| SCHEMBL5510292 | 0.70 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL30587393 | 0.70 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL3197673 | 0.70 | ALDH1A1 (0.37) | KDM4EALDH1A1MAPTCYP3A4THRB | |
| SCHEMBL14290261 | 0.69 | ADORA1 (0.34) | KDM4EALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL24607999 | 0.67 | PTGER4 (0.34) | ALDH1A1CYP3A4ALOX15SMN1; SMN2TDP1 | |
| SCHEMBL11901399 | 0.67 | ALDH1A1 (0.32) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107847588-B | Molecular construct with targeting and effector moieties and uses thereof | 免疫功坊股份有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-107106683-B | Molecular construct comprising targeting and effector components | 中央研究院 | 2021-07-20 | — | — | CN | claimed |
| CN-108431045-A | Molecular construct for preventing and/or treating thrombosis | 免疫功坊股份有限公司 | 2018-08-21 | — | — | CN | claimed |
| CN-107847588-A | Molecular construct with targeting and effector moieties and uses thereof | 免疫功坊股份有限公司 | 2018-03-27 | — | — | CN | claimed |
| CN-107106683-A | Molecular construct comprising targeting and effector components | 中央研究院 | 2017-08-29 | — | — | CN | claimed |
| CN-108431045-B | Molecular construct for preventing and/or treating thrombosis | 免疫功坊股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-107847588-B | Molecular construct with targeting and effector moieties and uses thereof | 免疫功坊股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-107106683-B | Molecular construct comprising targeting and effector components | 中央研究院 | 2021-07-20 | — | — | CN | disclosed |
| CN-108431045-A | Molecular construct for preventing and/or treating thrombosis | 免疫功坊股份有限公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-107847588-A | Molecular construct with targeting and effector moieties and uses thereof | 免疫功坊股份有限公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-107106683-A | Molecular construct comprising targeting and effector components | 中央研究院 | 2017-08-29 | — | — | CN | disclosed |